Medical Properties Trust, Inc. (MPT) Stock Forecast
MPT analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.12 / 5 from 8 analysts
- Price target
- $5.12 average of analyst targets
- Upside to target
- +70.3% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $0.13
- 52-week range
- $3.01 – $6.02
MPT analyst ratings
8 analystsNumber of analysts at each rating.
MPT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MPT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | −$0.13 | +108.3% | 1 |
| Current fiscal year (2026) | $0.10 | $0.06 | $0.15 | −$0.46 | +122.8% | 2 |
| Next fiscal year (2027) | $0.05 | $0.03 | $0.07 | $0.11 | −9.1% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MPT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $262.5M | $258.8M | $265.7M | +10.5% | 4 |
| Current fiscal year (2026) | $1.04B | $1.03B | $1.04B | +6.8% | 5 |
| Next fiscal year (2027) | $1.08B | $1.06B | $1.10B | +3.9% | 5 |
MPT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MPT revenue: reported and forecast
MPT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.04 | $0.04 | $0.00 | $0.00 | $0.00 | −100.0% | 0 up · 0 down |
| Current fiscal year (2026) | $0.13 | $0.12 | $0.06 | $0.06 | $0.10 | −16.7% | 0 up · 0 down |
| Next fiscal year (2027) | $0.15 | $0.15 | $0.11 | $0.10 | $0.05 | −65.9% | 0 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MPT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MPT beat in 3 of 12.
What analysts expect from MPT
8 analysts cover Medical Properties; their consensus rating is hold (3.12 on a 1–5 scale, where 5 is a strong buy). The average price target is $5.12, 70.3% above the latest close of $3.01. Analysts expect earnings of $0.10 per share for 2026, +122.8% from a year earlier. For 2027 the average estimate is $0.05 per share on revenue of $1.1 billion. Medical Properties beat the EPS estimate in 3 of the last 12 quarters.
Related: MPT income statement, MPT key metrics, MPT chart. See the MPT stock overview for the latest quote and news.
MPT forecast FAQ
What is Medical Properties's price target?
The average analyst price target for Medical Properties is $5.12, 70.3% above the latest close of $3.01.
Is Medical Properties a buy, hold or sell?
Of 8 analysts covering Medical Properties, 0 rate it a strong buy, 3 a buy, 3 a hold, 2 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Medical Properties's EPS forecast?
Analysts forecast $0.10 per share for 2026 (range $0.06 to $0.15); for 2027 the estimate is $0.05.
What is Medical Properties's revenue forecast?
The average revenue estimate for 2026 is $1.0 billion, growth of 6.8%; for 2027 it is $1.1 billion.
When does Medical Properties report earnings?
Medical Properties is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 before the market opens; the EPS estimate is $0.13.
Does Medical Properties usually beat earnings estimates?
Medical Properties reported EPS at or above the analyst estimate in 3 of the last 12 quarters.